咨询与建议

限定检索结果

文献类型

  • 2 篇 期刊文献
  • 1 篇 会议

馆藏范围

  • 3 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 3 篇 医学
    • 3 篇 临床医学

主题

  • 3 篇 car-nk cells
  • 1 篇 sting agonist
  • 1 篇 adoptive nk cell...
  • 1 篇 cord blood
  • 1 篇 human stem cells
  • 1 篇 cancer immunothe...
  • 1 篇 natural killer c...
  • 1 篇 cgamp,pancreatic...
  • 1 篇 sting
  • 1 篇 peripheral blood
  • 1 篇 chimeric antigen...
  • 1 篇 nk-92 cells
  • 1 篇 ipsc

机构

  • 1 篇 division of rege...
  • 1 篇 山东大学
  • 1 篇 institute of imm...
  • 1 篇 the first hospit...

作者

  • 1 篇 yuan hu
  • 1 篇 dan s.kaufman
  • 1 篇 yuxia liu
  • 1 篇 yanyan da
  • 1 篇 yi zhang
  • 1 篇 cai zhang
  • 1 篇 nan lu
  • 1 篇 jiuwei cui
  • 1 篇 huang zhu
  • 1 篇 feifei guo

语言

  • 3 篇 英文
检索条件"主题词=CAR-NK cells"
3 条 记 录,以下是1-10 订阅
排序:
STING agonist cGAMP enhances anti-tumor capability of car-nk cells against pancreatic carcinoma
STING agonist cGAMP enhances anti-tumor capability of CAR-NK...
收藏 引用
第十四届全国免疫学学术大会
作者: Cai Zhang Yanyan Da Yuxia Liu Yuan Hu Nan Lu Institute of Immunopharmacology and Immunotherapy School of Pharmaceutical SciencesShandong University 山东大学临床医学院
Activation of the stimulator of interferon gene(STING)-controlled innate pathway within the tumor microenvironment is a promising therapeutic strategy in many cancers.H owever,the effect of STING agonist on natural ki... 详细信息
来源: cnki会议 评论
Manufacturing car-nk against tumors: Who is the ideal supplier?
收藏 引用
Chinese Journal of Cancer Research 2024年 第1期36卷 1-16页
作者: Feifei Guo Yi Zhang Jiuwei Cui The First Hospital of Jilin University Cancer CenterChangchun 133021China
Chimeric antigen receptor-natural killer(car-nk) cells have emerged as another prominent player in the realm of tumor immunotherapy following car-T cells. The unique features of car-nk cells make it possible to compen... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy
收藏 引用
Blood Science 2019年 第1期1卷 4-11页
作者: Huang Zhu Dan S.Kaufman Division of Regenerative Medicine Department of MedicineUniversity of California San DiegoSan DiegoCAUSA
Adoptive immunotherapy using immune effector cells has revolutionized cancer treatments with approval of two autologous chimeric antigen receptor(car)T cell therapies by the US *** trials using natural killer(nk)cell-... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论